Brandi L. Roberts
2022 - Longboard Pharmaceuticals
In 2022, Brandi L. Roberts earned a total compensation of $861.2K as Executive Vice President and Chief Financial Officer at Longboard Pharmaceuticals, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,644 |
|---|---|
| Option Awards | $251,109 |
| Salary | $415,100 |
| Other | $12,325 |
| Total | $861,178 |
Roberts received $415.1K in salary, accounting for 48% of the total pay in 2022.
Roberts also received $182.6K in non-equity incentive plan, $251.1K in option awards and $12.3K in other compensation.
Rankings
In 2022, Brandi L. Roberts' compensation ranked 3,350th out of 5,758 executives tracked by ExecPay. In other words, Roberts earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,350 out of 5,758 | 42nd |
Division Manufacturing | 1,891 out of 3,135 | 40th |
Major group Chemicals And Allied Products | 902 out of 1,421 | 37th |
Industry group Drugs | 844 out of 1,322 | 36th |
Industry Pharmaceutical Preparations | 615 out of 968 | 37th |
Source: SEC filing on April 11, 2023.
Roberts' colleagues
We found two more compensation records of executives who worked with Brandi L. Roberts at Longboard Pharmaceuticals in 2022.
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020